We hypothesize that prostate cancer (CaP) associated gene expression signatures in specific cell types of the human prostate gland will define the pathobiology of epithelial and stromal components in prostate tumorigenesis, and a subset of these genes may predict the aggressive form of the disease. The objective of this proposal is to perform comparative genomics analyses on laser capture micro-dissected (LCM)- epithelial and stromal cells from prostate glands of carefully selected CaP patients and define gene clusters predictive of non-aggressive or aggressive form of the disease. Our experience with the gene expression analysis of LCM-epithelial cell RNAs, promising preliminary GeneChip data from LCM-epithelial cell RNAs, and development of a LCM DNA/RNA bank from CaP patients provide the basis for following specific aims proposed here.
Aim 1 : Identify CaP associated epithelial cells specific gene expression patterns: GeneChip defined expression patterns in paired normal and cancer epithelial cells from two CaP patient groups, one with """"""""aggressive CaP"""""""" (PSA recurrence, Gleason score 8-9, T3c stage, seminal vesicle invasion, poor tumor differentiation) and the other with """"""""non-aggressive CAP"""""""" (no PSA recurrence, Gleason score 6-7, T2a-T3b stage, no seminal vesicle invasion, well or moderate tumor differentiation), will be analyzed for CaP specific expression signatures. Emphasis will be placed on the gene clusters that define """"""""aggressive CAP"""""""".
Aim 2 : Identify CaP associated stromal cells specific gene expression patterns: Using similar strategy and same cohort of patients as for Aim1, CaP associated stromal cells specific gene expression patterns will be defined and emphasis will be placed on gene clusters associated with aggressive CaP.
Aim 3 : Validation of """"""""Aggressive CAP"""""""" associated epithelial or stromal cells specific genes: A panel of """"""""aggressive CAP"""""""" associated genes will be analyzed in a large cohort of patients by tissue microarray and/or quantitative real time PCR assay and its predictive value will be established. Significance: Epithelial or stromal cells specific gene expression patterns characteristics of CaP with potential roles in pathobiology will be defined. Gene clusters predictive of aggressive CaP has potential in: (1) providing novel modalities in the future clinical management of CaP; and (2) in identification of novel therapeutic targets for aggressive CaP.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK065977-02
Application #
6872013
Study Section
Special Emphasis Panel (ZRG1-UROL (52))
Program Officer
Rankin, Tracy L
Project Start
2004-03-15
Project End
2008-02-29
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
2
Fiscal Year
2005
Total Cost
$175,298
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
144676566
City
Rockville
State
MD
Country
United States
Zip Code
20817
Mohamed, Ahmed A; Tan, Shyh-Han; Xavier, Charles P et al. (2017) Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells. Mol Cancer Res 15:1308-1317
Shih, Jing-Wen; Wang, Ling-Yu; Hung, Chiu-Lien et al. (2015) Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism. Int J Mol Sci 16:28943-78
Hung, Chiu-Lien; Wang, Ling-Yu; Yu, Yen-Ling et al. (2014) A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A 111:18697-702
Derosa, C A; Furusato, B; Shaheduzzaman, S et al. (2012) Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression. Prostate Cancer Prostatic Dis 15:150-6
Sharad, S; Srivastava, A; Ravulapalli, S et al. (2011) Prostate cancer gene expression signature of patients with high body mass index. Prostate Cancer Prostatic Dis 14:22-9
Mohamed, Ahmed A; Tan, Shyh-Han; Sun, Chen et al. (2011) ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biol Ther 11:410-7
Mwamukonda, K; Chen, Y; Ravindranath, L et al. (2010) Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status. Prostate Cancer Prostatic Dis 13:47-51
Furusato, B; Tan, S-H; Young, D et al. (2010) ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer Prostatic Dis 13:228-37
Hawksworth, D; Ravindranath, L; Chen, Y et al. (2010) Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence. Prostate Cancer Prostatic Dis 13:311-5
Sun, C; Dobi, A; Mohamed, A et al. (2008) TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene 27:5348-53

Showing the most recent 10 out of 15 publications